COMMONWEALTH OF AUSTRALIA
National Health Act 1953
PHARMACEUTICAL BENEFITS
DECLARATION UNDER SUBSECTION 85(2AA)
No. PB 6 of 1991
I, FIONA MARGARET HOWARTH, Principal Advisor, Health Care Access Division, Department of Health, Housing and Community Services and Delegate of the Minister of State for Health, Housing and Community Services, having in accordance with subsection 85(2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85(2AA) of the National Health Act 1953, hereby make the following Declaration:
1. This Declaration shall come into operation on 1 August 1991.
2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.
THE SCHEDULE
Debrisoquine Sulphate
Difenoxin Hydrochloride with Atropine Sulphate
Flucytosine
Glucose, Anhydrous with Sodium Chloride, Potassium Chloride, Citric Acid and Sodium Citrate
Procarbazine Hydrochloride
Dated this eighteenth day of July 1991.
FIONA HOWARTH
Principal Advisor
Health Care Access Division
Department of Health, Housing and Community Services
Delegate of the Minister of State for Health, Housing and Community Services